Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
gsk medicines research centre, gunnels wood road, stevenage, SG1 2NY
Pomanda estimates the enterprise value of GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED at £0 based on a Turnover of £0 and 1.05x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED at £0 based on an EBITDA of £-28k and a 4.38x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED at £5.8b based on Net Assets of £4.5b and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Glaxosmithkline Intellectual Property Holdings Limited is a live company located in stevenage, SG1 2NY with a Companies House number of 08283289. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in November 2012, it's largest shareholder is
glaxo group limited
with a 100% stake. Glaxosmithkline Intellectual Property Holdings Limited is a established,
unknown sized company, Pomanda has estimated its turnover at
£0 with
unknown
growth in recent years.
Glaxosmithkline Intellectual Property Holdings Limited Health Check
Pomanda's financial health check has awarded Glaxosmithkline Intellectual Property Holdings Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 1 areas for improvement. Company Health Check FAQs
Health Rating1.5out of 5
1 Strong
1 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
Glaxosmithkline Intellectual Property Holdings Limited's latest turnover from December 2023 is 0 and the company has net assets of £4.5 billion. According to their latest financial statements, we estimate that Glaxosmithkline Intellectual Property Holdings Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Turnover
Other Income Or Grants
Cost Of Sales
Gross Profit
Admin Expenses
28,000
26,000
26,000
25,000
25,000
20,000
21,000
-239,217,000
33,000
16,000
15,000
Operating Profit
-28,000
-26,000
-26,000
-25,000
-25,000
-20,000
-21,000
239,217,000
-33,000
-16,000
-15,000
Interest Payable
197,000
51,000
8,000
6,000
1,000
Interest Receivable
75,999,000
21,814,000
85,000
1,820,000
9,137,000
7,227,000
2,415,000
3,175,000
6,228,000
3,925,000
83,000
Pre-Tax Profit
75,774,000
21,737,000
51,000
1,789,000
9,111,000
7,207,000
2,394,000
242,392,000
6,195,000
2,140,172,000
68,000
Tax
-17,807,000
-4,130,000
-10,000
-340,000
-1,731,000
-1,369,000
-461,000
-630,000
-1,254,000
-840,000
-16,000
Profit After Tax
57,967,000
17,607,000
41,000
1,449,000
7,380,000
5,838,000
1,933,000
241,762,000
4,941,000
2,139,332,000
52,000
Dividends Paid
239,243,000
2,039,959,000
9,026,981,000
Retained Profit
57,967,000
17,607,000
41,000
1,449,000
7,380,000
5,838,000
1,933,000
2,519,000
4,941,000
99,373,000
-9,026,929,000
Employee Costs
44,691
41,819
Number Of Employees
1
1
1
1
1
1
1
1
1
1
1
EBITDA*
-28,000
-26,000
-26,000
-25,000
-25,000
-20,000
-21,000
239,217,000
-33,000
-16,000
-15,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Tangible Assets
Intangible Assets
Investments & Other
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
Debtors (Due After 1 year)
1,709,641,000
1,633,642,000
Total Fixed Assets
4,500,017,000
4,424,018,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
2,790,376,000
Stock & work in progress
Trade Debtors
1,609,923,000
Group Debtors
1,611,829,000
1,611,743,000
1,601,248,000
1,594,650,000
1,593,521,000
1,191,219,000
3,124,231,000
724,745,000
Misc Debtors
Cash
20,000
41,000
42,000
35,000
misc current assets
total current assets
1,611,829,000
1,611,743,000
1,609,923,000
1,601,268,000
1,594,691,000
1,593,563,000
1,191,254,000
3,124,231,000
724,745,000
total assets
4,500,017,000
4,424,018,000
4,402,205,000
4,402,119,000
4,400,299,000
4,391,644,000
4,385,067,000
4,383,939,000
3,981,630,000
5,914,607,000
3,515,121,000
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
7,973,000
3,618,000
3,532,000
3,157,000
1,395,000
482,000
651,000
1,287,000
873,000
1,939,205,000
15,000
other short term finances
hp & lease commitments
other current liabilities
17,807,000
4,130,000
10,000
340,000
1,731,000
1,369,000
461,000
630,000
1,254,000
840,000
16,000
total current liabilities
25,780,000
7,748,000
3,542,000
3,497,000
3,126,000
1,851,000
1,112,000
1,917,000
2,127,000
1,940,045,000
31,000
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
25,780,000
7,748,000
3,542,000
3,497,000
3,126,000
1,851,000
1,112,000
1,917,000
2,127,000
1,940,045,000
31,000
net assets
4,474,237,000
4,416,270,000
4,398,663,000
4,398,622,000
4,397,173,000
4,389,793,000
4,383,955,000
4,382,022,000
3,979,503,000
3,974,562,000
3,515,090,000
total shareholders funds
4,474,237,000
4,416,270,000
4,398,663,000
4,398,622,000
4,397,173,000
4,389,793,000
4,383,955,000
4,382,022,000
3,979,503,000
3,974,562,000
3,515,090,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Operating Activities
Operating Profit
-28,000
-26,000
-26,000
-25,000
-25,000
-20,000
-21,000
239,217,000
-33,000
-16,000
-15,000
Depreciation
Amortisation
Tax
-17,807,000
-4,130,000
-10,000
-340,000
-1,731,000
-1,369,000
-461,000
-630,000
-1,254,000
-840,000
-16,000
Stock
Debtors
75,999,000
21,813,000
86,000
1,820,000
8,675,000
6,598,000
1,129,000
402,302,000
-1,933,012,000
2,399,486,000
724,745,000
Creditors
Accruals and Deferred Income
13,677,000
4,120,000
-330,000
-1,391,000
362,000
908,000
-169,000
-624,000
414,000
824,000
16,000
Deferred Taxes & Provisions
Cash flow from operations
-80,157,000
-21,849,000
-452,000
-3,576,000
-10,069,000
-7,079,000
-1,780,000
-164,339,000
1,932,139,000
-2,399,518,000
-724,760,000
Investing Activities
capital expenditure
Change in Investments
2,790,376,000
cash flow from investments
-2,790,376,000
Financing Activities
Bank loans
Group/Directors Accounts
4,355,000
86,000
375,000
1,762,000
913,000
-169,000
-636,000
414,000
-1,938,332,000
1,939,190,000
15,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
400,000,000
360,099,000
12,542,019,000
interest
75,802,000
21,763,000
77,000
1,814,000
9,136,000
7,227,000
2,415,000
3,175,000
6,228,000
3,925,000
83,000
cash flow from financing
80,157,000
21,849,000
452,000
3,576,000
10,049,000
7,058,000
1,779,000
403,589,000
-1,932,104,000
2,303,214,000
12,542,117,000
cash and cash equivalents
cash
-20,000
-21,000
-1,000
7,000
35,000
overdraft
change in cash
-20,000
-21,000
-1,000
7,000
35,000
glaxosmithkline intellectual property holdings limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for glaxosmithkline intellectual property holdings limited. Get real-time insights into glaxosmithkline intellectual property holdings limited's credit score, group structure and payment trends.
Perform a competitor analysis for glaxosmithkline intellectual property holdings limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other established companies, companies in SG1 area or any other competitors across 12 key performance metrics.
Glaxosmithkline Intellectual Property Holdings Limited currently has 5 directors.
The longest serving directors include
Mr Adam Walker (Mar 2013) and
Mr Graham Rivers (Jul 2023).
glaxosmithkline intellectual property holdings limited company details
company number
08283289
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to glaxosmithkline intellectual property holdings limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED. This can take several minutes, an email will notify you when this has completed.
glaxosmithkline intellectual property holdings limitedCompanies House Filings - See Documents
